NSEK Trademark

Trademark Overview

On Wednesday, December 4, 2024, a trademark application was filed for NSEK with the United States Patent and Trademark Office. The USPTO has given the NSEK trademark a serial number of 98884999. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 4, 2024. This trademark is owned by Emmetrope Ophthalmics LLC. The NSEK trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services relating to the injection of human cells into the eye; medical treatment using cells; Regenerative medicine services; Consulting in the fields of ophthalmology and health as it relates to cell therapy
nsek

General Information

Serial Number98884999
Word MarkNSEK
Filing DateWednesday, December 4, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, December 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical services relating to the injection of human cells into the eye; medical treatment using cells; Regenerative medicine services; Consulting in the fields of ophthalmology and health as it relates to cell therapy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmmetrope Ophthalmics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Wednesday, December 4, 2024NEW APPLICATION ENTERED

Related Keywords

nsek medical cells services ophthalmology fields health relates therapy cell consulting